Broadwing Bio Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Broadwing Bio is a biotechnology research company focused on developing antibody therapies for eye diseases. It concentrates on targets supported by genetic validation with the aim of addressing glaucoma and geographic atrophy in patients. The company’s work centers on therapies intended to help preserve sight in those affected by these common causes of vision loss. Based in South San Francisco, California, Broadwing Bio operates with a small team and maintains a website at broadwing.bio. The company began in 2020 through a collaboration between Maze Therapeutics and Alloy Therapeutics to pursue antibody-based therapies for eye diseases.